Drug intelligence / Profile preview

Zicam Cough Melts

Development stage
Unknown
Lead developer
Matrixx Initiatives
Modality
Small Molecules
Administration
Oral
01

Overview

Zicam Cough Melts is an over-the-counter antitussive medication indicated for the temporary relief of cough due to minor throat and bronchial irritation, such as those associated with the common cold or inhaled irritants. Unlike many other products under the Zicam brand that are marketed as homeopathic remedies, Zicam Cough Melts is a conventional pharmaceutical product containing the active ingredient dextromethorphan hydrobromide. Dextromethorphan is a synthetic d-isomer of the codeine analog levorphanol and acts centrally in the medulla oblongata to raise the cough threshold. Its primary mechanism of action involves agonism of the sigma-1 receptor and non-competitive antagonism of the N-methyl-D-aspartate (NMDA) receptor. The product is uniquely formulated as an orally disintegrating tablet (melt) to allow for rapid dissolution and administration without the need for water.

Brand names
Zicam Cough Melts
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)SIGMAR1 (Sigma non-opioid intracellular receptor 1)

Beyond the preview

Go deeper on Zicam Cough Melts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zicam Cough Melts.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call